Immuneering stock maintained at Outperform by Oppenheimer on survival data

Immuneering stock maintained at Outperform by Oppenheimer on survival data

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.